Literature DB >> 17321075

Structure of the human 5-HT7 receptor gene and characterization of its promoter region.

Koen Laenen1, Guy Haegeman, Peter Vanhoenacker.   

Abstract

The molecular mechanism regulating serotonin 5-HT(7) receptor expression is still unclear. In this study we provide evidence that transcription of the 5-HT(7) gene is at least partly regulated by Sp1 and Sp3. We isolated and sequenced >3000 bp of the upstream sequences and identified by RACE a number of transcriptional initiation sites over a region of 300 bp upstream of the coding region. This region has a high GC content, but contains no obvious TATA or a CAAT box. Besides a Sp1/Sp3 consensus motif, regulatory elements for AP2, Egr-1 and MAZ are also present. Transient transfection assays using deletion variants indicated that the GC-rich region is essential for full promoter activity. The role of Sp1 in this was confirmed by transient overexpression of both wild type Sp1 or dominant-negative forms. By gel shift and supershift analyses, targeting the Sp1 consensus sequence and the GC-rich region just upstream of the transcription initiation sites, binding of Sp1 and Sp3 was demonstrated. Both in vitro as well as in vivo experiments, using a cell line which endogenously expresses the 5-HT(7) receptor, indicated that mithramycin A, an inhibitor of Sp1/3 transcription factor binding, was able to inhibit 5-HT(7) promoter activity. Taken together these results support the essential role of Sp factors in regulating 5-HT(7) promoter activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17321075     DOI: 10.1016/j.gene.2007.01.003

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

Review 1.  Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives.

Authors:  Anne Matthys; Guy Haegeman; Kathleen Van Craenenbroeck; Peter Vanhoenacker
Journal:  Mol Neurobiol       Date:  2011-03-22       Impact factor: 5.590

2.  HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation.

Authors:  Xiaoli Sheng; Wenlin Liu; Zhongming Lu; Mimi Xu; Rui Li; Rong Zhong; Yunxian Li; Tao Liu; Siyi Zhang
Journal:  Ann Transl Med       Date:  2021-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.